Navigation Links
Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
Date:2/4/2010

DURHAM, N.C., Feb. 4 /PRNewswire/ -- Gorbec Pharmaceutical Services, a rapidly expanding contract developer and manufacturer of prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory in Yantai, China.  This new facility will expand Gorbec's current services for analytical method development and testing.  Gorbec is taking this action to better serve its U.S. customer base as well as develop a presence in the emerging Asian market.

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for U.S.-based customers.  Gorbec's future plans call for an increased capacity to develop and submit New Drug Applications (NDA'S) and will require an expansion of analytical services.  In an effort to improve efficiencies and reduce costs, the company has elected to locate the new analytical facility in China.  The company's core business services, current analytical laboratory, and commercial manufacturing will remain in the U.S.  The China facility is expected to open May 1st, 2010 but Gorbec is already working with customers who have plans to use some of the new facility's capacity.

The Yanti facility will operate under the direction of Gorbec's Vice President of Analytical Chemistry, Dr. Jing Chen.  Dr. Chen received her PhD from Stanford University and brings a wealth of pharmaceutical experience to the operation.  She joined Gorbec after holding various positions at Genentech Inc. and Alza Corporation.  Working with Dr. Chen will be Yan Zhang who will oversee the daily operations locally in Yantai.

Gorbec's Founder and CEO, Mike Gorman added, "We are very excited about our future and our ability to offer a GMP laboratory in China.  This new location will allow us to serve our own needs as well as the needs of companies looking to develop and distribute pharmaceutical products for the Asian Market."

About Gorbec

Gorbec Pharmaceutical Services, Inc. is a privately held company providing complete pharmaceutical development and manufacturing services.  Gorbec's highly experienced management team has driven the company to become a leader in the field of cGMP contract manufacturing services.  The company is focused primarily on the development of new drugs products that fill specialty niches within the traditional segment of the pharmaceutical business.

SOURCE Gorbec Pharmaceutical Services, Inc.

RELATED LINKS
http://www.gorbec.com

'/>"/>

SOURCE Gorbec Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
2. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
3. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
7. Americas Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
8. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
9. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
10. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Valve Devices Market: Analysis By Procedure, Replacement Procedure By Technique, Repair ... their offering. ... Global Heart Valve Devices Market is forecasted to grow at a ... heart valve devices is driven by rising aging population, growth in ...
(Date:3/23/2017)... and INDIANAPOLIS , March ... LLY ) and the William Sansum Diabetes Center ... of Latino people affected by diabetes through enhanced research, ... of diabetes and cardiovascular disease bears a disproportionate weight ... ," said David Kerr , M.D., FRCPE, ...
(Date:3/23/2017)... , March 23, 2017 ... and Healthcare disease pipeline guide Primary Hyperoxaluria - ... the Primary Hyperoxaluria (Genito Urinary System And Sex ... rare condition characterized by recurrent kidney and bladder ... substance called oxalate. Symptoms include blood in the ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating their commitment to ... public health departments have been awarded national accreditation through the Public Health ... the expanding network of communities across the nation whose health departments meet rigorous ...
(Date:3/23/2017)... Montclair, NJ (PRWEB) , ... March 23, 2017 ... ... the Renaissance Oklahoma City Convention Center at 10 North Broadway Avenue, will be ... 6.0 hours of relevant, practical instruction in the management of chronic pain. , ...
(Date:3/23/2017)... New Holland, PA and Grimsby, Ontario (PRWEB) , ... March 23, 2017 , ... The ... to the modular industry or whose acts have had a significant impact on the careers ... of Sales and Marketing with NRB Inc. was inducted into the MBI’s Hall of Fame. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Dilger-Maxwell ... of the Norwalk and Vermillion areas, celebrates the newest charity campaign in ... nonprofit, community-based substance abuse prevention and peer recovery support organization providing vital ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
Breaking Medicine News(10 mins):